Eva Baerends

Aarhus University - Department of Infectious Diseases

SCHOLARLY PAPERS

1

DOWNLOADS

88

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

SARS-CoV-2 Vaccine-Induced Antibodies Protect Against Omicron Breakthrough Infection

Number of pages: 20 Posted: 24 Feb 2023
Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, University of Copenhagen - Centre of Excellence for Health, Immunity and Infections CHIP, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, University of Copenhagen - Centre of Excellence for Health, Immunity and Infections CHIP, Aalborg University - Department of Infectious Diseases, Aalborg University - Department of Infectious Diseases, Aalborg University - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Zealand University Hospital - Department of Infectious Diseases, Zealand University Hospital - Department of Medicine, Zealand University Hospital - Department of Medicine, University of Copenhagen - Department of Infectious Diseases, University of Copenhagen - Department of Cardiology, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, University of Copenhagen - Department of Public Health, Aarhus University - Department of Clinical Immunology, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, University of Copenhagen - Centre of Excellence for Health, Immunity and Infections CHIP, Aarhus University - Department of Infectious Diseases and Aarhus University - Department of Infectious Diseases
Downloads 88 (584,356)

Abstract:

Loading...

SARS-CoV-2, Omicron, COVID-19, Breakthrough Infection, Antibodies, Vaccination, Seroconversion, Case-Control